GFAP and Schnyder corneal dystrophy: The more severe the cognitive impairment, the higher the levels of plasma GFAP, NfL, and p-tau181 [7], and alterations in the plasma GFAP, NfL, and p-tau181 content depends on the stage of subjective cognitive function decline (SCD) and MCI [14].